A seven-year study on the effect of the pre-erythrocytic malaria vaccine candidate RTS,S/AS01 <sub>E</sub> on blood stage immunity in young Kenyan children.

Wellcome Open Res · 2019 · PMC6545824 · PMID 31168483

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

modest significanceno p-value reported

Overall, the unadjusted data supports (albeit with modest significance at most time points) the main conclusion that humoral immunity to tested blood-stage antigens is hampered or delayed by RTS,S vaccination, and this reduction in immunity is extended for years after vaccination.

also in 149 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

A seven-year study on the effect of the pre-erythrocytic malaria vaccine candidate RTS,S/AS01 &lt;sub&gt;E&lt;/sub&gt; on blood stage immunity in young Kenyan children.

The sentences

A seven-year study on the effect of the pre-erythrocytic malaria vaccine candidate RTS,S/AS01 <sub>E</sub> on blood stage immunity in young Kenyan children.